Background
==========

Cluster-based studies involving aggregated units such as hospitals, health centers, schools or medical practices are increasingly being used in healthcare evaluation, especially in cluster randomized trials, which are perhaps the most high impact form of public health research/evaluation study design that can benefit from good extent estimates of ICC. In such situations, population groups (specific geographical areas), healthcare units (hospitals) or healthcare sectors are considered primary sampling units and generally all subjects belonging to each group are included to obtain data of interest \[[@B1],[@B2]\].

However, depending on the method of selection, data obtained from clusters may not be sufficiently representative to allow for generalization. Population observed in clusters can present a large degree of similarity in some characteristics (homogeneity), unlike when there is a simple random sampling (SRS), in which each individual has the same probability of being selected in the general population, with more heterogeneity \[[@B2]\].

Therefore, an important characteristic of cluster-based studies is to evaluate the proportion of data variability that is explained by means of clustering, and this reliability may be analyzed by measuring inter and intracluster variance \[[@B3]\].

Intracluster correlation coefficient (ICC), denoted by ρ, is defined as the ratio of the between-cluster variance to the total variance (both between and within clusters), and therefore has a value between 0 and 1 \[[@B4],[@B5]\]. Its value depends on the type of variable, cluster size and the prevalence of the condition \[[@B6]\]. Coefficients close to zero indicate that individuals within clusters are no more similar to each other than individuals from different clusters (the variable is randomly distributed among clusters); otherwise the values close to 1 reflect the homogeneity in a sample \[[@B7]\]. In other words, for cluster based population studies this heterogeneity (ICC close to zero) is desired as a proxy to the subjects being randomly selected.

The increase in variance due to clustering, compared to what would be obtained if sampling had been carried out by the SRS method, is calculated by design effect (Deff) \[[@B8]\]. It is given by 1 + (*m*-1) *ICC*, where *m* is the average cluster size \[[@B9]\]. Deff value is directly proportional to ICC and to the size of a cluster \[[@B10]\].

The ICC estimate in cluster studies is very useful for the development of new studies in the same field, because values obtained could be used as a correction factor for the calculation of sample size needed, thus avoiding underestimates, since in studies in which SRS is used, the sample size required to achieve sufficient statistical power is usually smaller \[[@B4]\].

The purpose of this manuscript is to evaluate the ICC of variables studied in the Brazilian Multicenter Study on Preterm Birth, a multicenter cross-sectional study on preterm births involving 20 referral hospitals in different regions of Brazil plus a nested case--control study. Estimated prevalence rates or means, ICC with 95% confidence intervals, design effects and average cluster sizes were also objectives for this study and they are presented for more than 250 maternal and neonatal variables.

Methods
=======

The Brazilian Multicenter Study on Preterm Birth consisted of a multicenter cross-sectional study plus a nested case--control study to assess their associated factors implemented in referral obstetrical units (clusters) from several states of the country. The full research proposal has already been published elsewhere \[[@B11]\].

A single-stage cluster sampling was used. Clusters were selected by an invitation to 27 healthcare institutions that build a national network called Brazilian Network for Studies on Reproductive and Perinatal Health. They are located in the five geographical regions of the country, almost all of them are public institutions, and all of them receive both low and high risk pregnant women. Initially 26 centers accepted to participate, but 20 selected institutions were able to fully take part in the study.

The sample size was calculated using the official prevalence of preterm births in Brazil of around 6.5% \[[@B12]\]. Considering an acceptable absolute difference of about 0.25% between the sample and the population prevalence, and a type I error of 5%, initial surveillance of a sample size of 37,000 deliveries was necessary. For the case--control study component, the estimated sample size was 1,055 women in each group (cases and controls). The total number of preterm births estimated to be followed in both components of the study was around 3,600.

The participating centers performed a prospective surveillance of all patients admitted to give birth in order to identify preterm births. For this purpose and according to standard international definitions, preterm birth was considered that occurring before 37 completed weeks of gestational age evaluated by an ultrasound scan performed early in pregnancy, by a known date of the last menstrual period, or alternatively by the evaluation of the somatic age of the newborn. During the first months of the study, in order to complete the sample for the appropriate analysis of the factors associated with spontaneous preterm birth, a random sample of women who had full-term birth was also selected.

Data was collected during six to twelve months for each center, from April 2011 to March 2012, in a detailed form called "Questionnaire" including 306 variables from four sources: interview with women in the postpartum period, medical records and prenatal chart of the mother (before hospital discharge), and newborn medical records (within sixty days after birth, even if it remained in hospital for longer period). An electronic system of data entry called *OpenClinica*® was selected and a proper clinical research form (CRF) was designed for the input of data after the questionnaire of each case was completed and reviewed.

High quality data and reliable information was guaranteed by several steps: preparatory meetings, development of detailed manuals of operation, monitoring technical site visits to the centers, close monitoring of data collection and data entry, concurrent query management, checking for logical inconsistencies, and correction of database. The research proposal was firstly approved by the Institutional Review Board of the coordinating center and then confirmed by IRB of each other participating center.

Data analysis
-------------

In this study, each of the 20 participating centers (hospital) was considered a primary sampling unit (PSU) and there was no stratification of the PSU or weighting of the data. The subject (unit of analysis) was woman who delivered preterm (case) or at term (control).

Estimated prevalence (categorical variables) or means (continuous numeric variables), intracluster correlation coefficients (ICC), their respective 95% confidence intervals (CI), design effects (Deff) and mean cluster size of each variable were calculated. Software programs used for analysis were SPSS® version 20.0 \[[@B13]\] and Stata version 7.0 \[[@B14]\], taking into consideration the cluster sampling plan (centers) for data analysis.

According to Kish \[[@B2]\], ICC (*Roh*) is: ρ = (*s*^2^~*a*~ − *s*^2^~*b*~/*b*)*/s*ˆ^2^, where *s*^2^~*a*~ is the variance between clusters; *s*^2^~*b*~ is the variance within clusters, b is the size of clusters and *s*ˆ^2^ is the estimate of *S*^2^ (variance in individual level). The estimate *s*ˆ^2^ is obtained by: *s*ˆ^2^ = *s*^2^~*a*~ + \[(*b* − 1)/*b*\]*s*^2^~*b*~. Stata's equivalent computing formula for ICC \[[@B14]\] is: ICC = \[(*F* − 1)*a*/*n*\]/1 + (*F* − 1)*a*/*n*, where 'F' is the Snedecor's F-value from the ANOVA table and 'a' is the number of groups. The variance estimate for ICC is obtained by an extensive asymptotic formula and because this it was not showed.

For this study, the Design effect - DEFF \[[@B2]\] is *Deff* = var~actual~(*r*)/var~SRS~(*r*) = *s*^2^*a*/*a*/*s*^2^/*n*) where var~actual~(r) is the estimated variance according to the complex design being studied and var~SRS~(r) is the variance in the estimator considering the design as if it were calculated using a SRS of the same size, *n*.

Results
=======

During fifteen months, 5,296 births were included in the study, 4,150 of them being preterm births (1,491 due to spontaneous preterm labor, 1,191 due to a prelabor premature rupture of membranes and 1,468 due to a therapeutic interruption of pregnancy either for a maternal or fetal condition) and a sample of 1,146 term births to be used as controls for the case--control component.

Clustering was not stratified by region. Proportionally more centers were located in the Southeast of the country and consequently over half of births were from this region (11/20 -- 53.5%). The other centers were from Northeast region (7/20 -- 35%), contributing with 34.8% of births studied, South region (2/20 -- 10%), with 11.7% of births. The mean size of each cluster was 265 cases.

Estimated ICCs
--------------

Estimated ICCs are presented in Tables [1](#T1){ref-type="table"}, [2](#T2){ref-type="table"}, [3](#T3){ref-type="table"}, [4](#T4){ref-type="table"}, [5](#T5){ref-type="table"}, [6](#T6){ref-type="table"}, [7](#T7){ref-type="table"}, [8](#T8){ref-type="table"}, [9](#T9){ref-type="table"} and [10](#T10){ref-type="table"} for each of 261 variables. Tables [2](#T2){ref-type="table"} and [8](#T8){ref-type="table"} show results for continuous numeric variables, while other tables present results for categorical variables or were categorized for analysis. In addition to ICC, the 95% confidence interval (CI), the design effect (Deff) and the mean cluster size (n~a~), as well as the estimated prevalence (or mean) are presented. ICC ranged from \<0.001 to 0.965, with a median of 0.028. ICC was \< 0.1 in 78.5% of the variables and \< 0.3 for 95% of them.

###### 

**Estimates of prevalence (P), intracluster correlation coefficients (ICC), their respective 95% CI, design effect (Deff), and mean cluster size (n**~**a**~**) for categorical maternal characteristics**

  **Variables**                                 **P (%)**   **ICC**   **95% CI for ICC**   **Deff**   **n**~**a**~
  -------------------------------------------- ----------- --------- -------------------- ---------- --------------
  Skin color (white)                              43.1       0.145       0.058-0.233         42.2         265
  Marital status (with a partner)                 77.7       0.008      \<0.001-0.016        3.2          265
  Schooling (\>8 years)                           60.5       0.030       0.008-0.053         10.6         261
  Children under 5 years (≥1)                     27.1       0.005      \<0.001-0.011        2.4          265
  Time since last delivery (until 12 months)       8.4       0.011      \<0.001-0.022        2.8          155
  Previous cerclage                                1.1       0.001      \<0.001-0.004        1.2          264
  Previous preterm birth                          17.3       0.007      \<0.001-0.013        3.2          264
  Previous preterm birth of multiples              1.0      \<0.001     \<0.001-0.003        1.2          264
  Previous preterm labor                           7.4       0.011       0.001-0.021         4.3          264
  Previous prelabor PROM                           7.2       0.002      \<0.001-0.006        1.8          264
  Previous indicated preterm birth                 7.7       0.004      \<0.001-0.009        2.0          263
  Previous newborn weight \< 2500 g               14.8       0.010      \<0.001-0.019        4.1          262
  **Previous chronic diseases:**                                                                     
     ● Chronic hypertension                        8.2       0.004      \<0.001-0.009        2.4          265
     ● Diabetes mellitus                           2.1       0.010       0.001-0.019         3.6          265
     ● Thyroid disease                             1.8       0.012       0.002-0.023         4.4          265
     ● Cardiac disease                             1.3       0.002      \<0.001-0.005        1.4          265
     ● Lung disease                                2.9       0.006      \<0.001-0.012        2.8          265
     ● Renal disease                               1.8       0.013       0.002-0.024         4.7          265
     ● Digestive disease                           1.3       0.009       0.001-0.018         3.3          265
     ● Hematological disease                       1.4       0.012       0.002-0.023         4.7          265
     ● Neurological disease                        1.2       0.008      \<0.001-0.016        3.7          265
     ● Psychiatric disease                         1.4       0.022       0.005-0.038         7.0          265
     ● HIV                                         1.3       0.006      \<0.001-0.012        2.6          265
     ● Other                                       6.5       0.033       0.009-0.057         11.8         265

###### 

**Estimates of mean, intracluster correlation coefficients (ICC), their respective 95% CI, design effect (Deff), and mean cluster size (n**~**a**~**) for numeric maternal characteristics**

  **Variable**                         **Mean**   **ICC**   **95% CI for ICC**   **Deff**   **n**~**a**~
  ----------------------------------- ---------- --------- -------------------- ---------- --------------
  Age (years)                            26.1      0.018       0.004-0.033         5.3          265
  Month stopped working                  6.9       0.015      \<0.001-0.032        2.6           99
  Workload (hours daily)                 8.0       0.040       0.007-0.072         6.9           98
  Pre-pregnancy weight (Kg)              62.1      0.021       0.005-0.038         6.6          250
  Height (m)                             1.6       0.041       0.011-0.071         9.8          238
  Final weight (Kg)                      73.2      0.022       0.005-0.040         6.4          237
  Weight gain in pregnancy (Kg)          10.9      0.012       0.001-0.023         4.5          229
  Initial Body Mass Index (Kg/m^2^)      24.4      0.012       0.001-0.024         4.5          230
  Final Body Mass Index (Kg/m^2^)        28.7      0.016       0.002-0.030         5.5          220
  Number of pregnancies                  2.4       0.006      \<0.001-0.013        2.8          265
  Number of vaginal deliveries           0.8       0.005      \<0.001-0.011        2.5          265
  Number of cesarean sections            0.3       0.014       0.002-0.025         4.7          265
  Number of abortions                    0.3       0.006      \<0.001-0.013        2.3          265
  Number of uterine curettage            0.2       0.008      \<0.001-0.015        2.9          264

###### 

**Estimates of prevalence (P), intracluster correlation coefficients (ICC), their respective 95% CI, design effect (Deff), and mean cluster size (n**~**a**~**) for maternal socio-demographic characteristics**

  **Variable**                     **P (%)**   **ICC**   **95% CI for ICC**   **Deff**   **n**~**a**~
  ------------------------------- ----------- --------- -------------------- ---------- --------------
  Household (rural)                   9.8       0.097       0.034-0.159         32.9         264
  Homeownership                      57.5       0.041       0.012-0.070         15.2         265
  Paved street                       78.7       0.181       0.077-0.286         60.0         262
  Piped water                        94.2       0.090       0.031-0.149         30.0         263
  Sewer                              86.8       0.191       0.083-0.300         53.8         261
  Family income (\>US\$ 400.00)      38.8       0.103       0.037-0.168         28.8         244
  Paid work                          42.6       0.036       0.010-0.063         10.8         263
  Paid work in pregnancy             88.8       0.041       0.008-0.073         7.4          112
  Strenuous work                     43.4       0.037       0.006-0.068         5.5           99
  Standing work                      61.4       0.017      \<0.001-0.034        2.8           99
  Night work                         19.5       0.033       0.004-0.061         4.3           98
  Housework (alone)                  50.7       0.019       0.004-0.034         7.3          265

###### 

**Estimates of prevalence (P), intracluster correlation coefficients (ICC), their respective 95% CI, design effect (Deff), and mean cluster size (n**~**a**~**) for categorical variables of process during pregnancy**

  **Variable**                                   **P (%)**   **ICC**   **95% CI for ICC**   **Deff**   **n**~**a**~
  --------------------------------------------- ----------- --------- -------------------- ---------- --------------
  Healthcare facility used for prenatal care:                                                         
     ● Primary health care unit                    71.3       0.117       0.044-0.191         31.1         256
     ● Hospital                                    34.3       0.185       0.079-0.291         46.2         256
     ● Private clinic                               9.3       0.051       0.015-0.086         15.9         256
     ● Other                                        0.3       0.005      \<0.001-0.011        2.4          256
     ● Without prenatal care                        3.2       0.003      \<0.001-0.008        2.2          256
  Prenatal care by physician                       89.7       0.195       0.085-0.305         64.5         256
  Start of prenatal care (1^st^ trimester)         64.8       0.034       0.009-0.059         8.9          219
  Number of prenatal care visits (≥6)              58.8       0.054       0.016-0.092         13.7         231
  Ultrasound during prenatal care                  98.4       0.001      \<0.001-0.004        1.4          254
  Physical effort                                  42.0       0.053       0.016-0.089         14.8         263
  Depression                                       32.5       0.073       0.024-0.122         26.2         263
  Anxiety                                          65.5       0.099       0.035-0.163         38.0         263
  Smoking                                          13.5       0.020       0.004-0.036         7.7          265
  Use of alcohol                                   15.9       0.031       0.008-0.054         10.2         263
  Illicit drugs use (during or before)              4.9       0.015       0.002-0.027         5.8          265
  Vaginal discharge treatment (self-reported)      36.6       0.010       0.001-0.020         4.1          264
  Vulvovaginitis:                                                                                            
     ● Bacterial vaginosis                         12.9       0.039       0.008-0.069         11.1         160
     ● Candidiasis                                 13.5       0.061       0.016-0.106         11.2         160
     ● Trychomoniasis                               1.4       0.011      \<0.001-0.023        4.9          160
     ● Other vulvovaginitis                         0.9       0.030       0.005-0.054         6.2          160
  Vulvovaginitis treatment (registered)            24.1       0.073       0.020-0.126         15.1         164
  Urinary infection treatment (self-reported)      36.3       0.018       0.004-0.032         6.7          261
  Urinary infection (registered)                   32.9       0.032       0.008-0.057         10.0         209
     ● Asymptomatic bacteriuria                    15.7       0.084       0.027-0.140         23.2         184
     ● Cystitis                                     7.1       0.028       0.006-0.050         7.9          184
     ● Pyelonephritis                               2.0       0.003      \<0.001-0.008        2.0          184
  Urinary treatment (registered)                    2.1       0.075       0.023-0.126         18.2         184
  Periodontal infection                            17.0       0.036       0.010-0.063         14.5         262
  Other infection                                   9.1       0.019       0.004-0.035         7.5          263
     ● Unknown fever                                1.8       0.024       0.006-0.043         11.1         265
     ● Diarrhea fever                               0.9       0.006      \<0.001-0.012        3.2          265
     ● HIV - diagnosis in pregnancy                 0.6       0.002      \<0.001-0.006        2.1          265
     ● Pneumonia                                    0.5      \<0.001     \<0.001-0.003        1.2          265
     ● Tuberculosis                                \<0.1     \<0.001     \<0.001-0.003        0.8          265
     ● Sinusitis/tonsillitis                        3.4       0.015       0.003-0.028         6.7          265
     ● Hepatitis                                    0.2       0.007      \<0.001-0.014        4.2          265
     ● Genital herpes                              \<0.1      0.001      \<0.001-0.004        1.4          265
     ● Toxoplasmosis                                0.5       0.009      \<0 001-0.018        3.4          265
  Anemia                                           29.2       0.046       0.013-0.078         13.4         259
  Iron replacement                                 84.9       0.037       0.001-0.063         12.1         264
  Bleeding                                         23.9       0.012       0.001-0.022         4.6          264
     ● Bleeding in first trimester                 12.2       0.006      \<0.001-0.013        2.6          264
     ● Bleeding in second trimester                 6.7       0.002      \<0.001-0.006        1.6          264
     ● Bleeding in third trimester                  6.3       0.013       0.002-0.024         6.1          264

###### 

**Estimates of prevalence (P), intracluster correlation coefficients (ICC), their respective 95% CI, design effect (Deff), and mean cluster size (n**~**a**~**) for categorical variables of process during pregnancy**

  **Variable**                         **P(%)**   **ICC**   **95% CI for ICC**   **Deff**   **n**~**a**~
  ----------------------------------- ---------- --------- -------------------- ---------- --------------
  Hospitalization                        22.3      0.030       0.008-0.052         10.0         265
  Reasons for hospitalization:                                                                    
     ● Emesis                            0.6       0.006       0.001-0.013         2.3          264
     ● Uterine contraction               5.7       0.014       0.002-0.026         5.3          264
     ● Amniorrhexis                      2.2       0.009       0.001-0.017         4.0          264
     ● Bleeding                          2.6       0.008      \<0.001-0.016        3.0          264
     ● Maternal disease                  8.9       0.029       0.007-0.050         10.1         264
     ● Fetal disease                     0.8       0.028       0.007-0.049         6.0          264
  Syphilis                               1.6       0.004      \<0.001-0.009        1.7          265
  Anemia (registered)                    32.0      0.070       0.023-0.118         24.1         238
  Treatment for anemia                   52.6      0.283       0.138-0.428         74.8         213
  Short cervix (US)                      1.4       0.011      \<0.001-0.022        4.0          209
  Cervical insufficiency                 2.1       0.005      \<0.001-0.012        2.6          230
  Cerclage                               1.4       0.019       0.003-0.034         5.6          238
  Uterine anomalies                      0.6      \<0.001     \<0.001-0.003        0.6          237
  Fibroid                                1.9       0.002      \<0.001-0.006        1.5          233
  Maternal diseases:                                                                              
     ● Diabetes                          5.7       0.027       0.006-0.047         7.8          254
     ● Gestational hypertension          7.7       0.025       0.006-0.045         9.4          254
     ● Preeclampsia/eclampsia/HELLP      16.2      0.062       0.019-0.104         22.5         254
     ● Chronic hypertension              5.7       0.007      \<0.001-0.014        2.8          254
     ● Other chronic infection           0.7       0.010       0.001-0.020         4.5          254
     ● Thyroid diseases                  1.6       0.027       0.006-0.047         8.2          254
     ● Renal disease                     1.2       0.008      \<0.001-0.015        3.1          254
     ● Sickle cell anemia                0.3       0.002      \<0.001-0.006        1.5          254
     ● Other chronic anemia              0.5      \<0.001     \<0.001-0.003        0.7          254
     ● Cardiac disease                   1.1       0.003      \<0.001-0.008        1.9          254
     ● Lung disease                      1.5       0.009      \<0.001-0.017        3.8          254
     ● Epilepsy                          0.6       0.001      \<0.001-0.004        1.5          254
     ● Systemic lupus erythematous       0.5       0.020       0.004-0.036         4.6          254
     ● Other collagenoses                0.2       0.001      \<0.001-0.004        1.4          254
     ● Digestive disease                 0.6       0.006      \<0.001-0.013        3.1          254
     ● Bariatric surgery                \<0.1     \<0.001     \<0.001-0.003        0.8          254
     ● Psychiatric disease               1.0       0.015       0.003-0.028         5.4          254
     ● Orthopedic disease                0.2      \<0.001     \<0.001-0.003        0.9          254
     ● Neoplasms                         0.2       0.001      \<0.001-0.004        1.4          254
     ● Thrombosis or thrombophilia       0.4       0.006      \<0.001-0.013        2.4          254
  Fetal malformation                     5.5       0.146       0.057-0.236         35.9         246
  Fetal growth restriction               9.3       0.019       0.004-0.035         6.9          246
  Other fetal morbidity                  7.4       0.386       0.219-0.554        101.5         246
  Triplets                               2.0      \<0.001     \<0.001-0.030        1.0           22
  Infertility treatment                  4.4      \<0.001     \<0.001-0.031        0.9           22
  Multiple monochorionic pregnancy       35.8      0.046      \<0.001-0.111        2.0           18
  Multiple monoamniotic pregnancy        5.8       0.038      \<0.001-0.098        1.9           18
  Twin-to-twin transfusion syndrome      5.4      \<0.001     \<0.001-0.036        0.9           18

###### 

**Estimates of prevalence (P), intracluster correlation coefficients (ICC), their respective 95% CI, design effect (Deff), and mean cluster size (n**~**a**~**) for categorical variables of process during labor**

  **Variable**                                        **P(%)**   **ICC**   **95% CI for ICC**   **Deff**   **n**~**a**~
  -------------------------------------------------- ---------- --------- -------------------- ---------- --------------
  Mode of onset of labor (spontaneous)                  55.3      0.018       0.004-0.032         6.5          265
  Intrapartum antibiotic (ATB)                          51.8      0.194       0.084-0.304         71.8         260
     ● ATB for fever                                    0.5       0.003      \<0.001-0.008        1.8          252
     ● ATB for GBS colonization                         1.9       0.019       0.004-0.034         5.6          252
     ● ATB for risk factor to GBS                       20.0      0.148       0.058-0.238         48.2         252
     ● ATB for other reasons                            29.1      0.384       0.217-0.550        148.0         252
  Analgesics during labor:                                                                                       
     ● Epidural                                         4.2       0.200       0.087-0.313         43.3         259
     ● Epidural plus spinal anesthesia                  3.7       0.201       0.088-0.314         74.3         259
     ● Spinal anesthesia                                20.1      0.338       0.181-0.495        112.8         259
     ● Meperidine                                       0.8       0.018       0.004-0.033         6.6          259
     ● Tramadol                                         0.2       0.002      \<0.001-0.006        1.4          259
     ● Benzodiazepines                                  0.1       0.008      \<0.001-0.017        3.6          259
     ● Antispasmodics                                   2.2       0.071       0.023-0.119         21.2         259
     ● Oral analgesics                                  2.0       0.091       0.031-0.150         23.0         259
     ● Other analgesics                                 2.4       0.102       0.036-0.168         46.6         259
  Mode of delivery (vaginal)                            48.8      0.024       0.006-0.043         7.7          265
  Episiotomy                                            38.7      0.176       0.068-0.283         31.5         126
  Forceps                                               3.9       0.056       0.014-0.099         12.9         116
  Cesarean indication:                                                                                           
     ● Fetal distress                                   25.7      0.016       0.001-0.031         3.8          133
     ● Cephalic-pelvic disproportion                    2.8       0.016       0.001-0.032         3.2          133
     ● Two or more cesarean scars                       9.8       0.006      \<0.001-0.014        2.0          133
     ● Pelvic or other abnormal fetal presentation      15.6      0.012      \<0.001-0.025        2.9          133
     ● Functional dystocia                              2.2       0.022       0.003-0.041         3.8          133
     ● Diabetes                                         1.8       0.013      \<0.001-0.027        3.3          133
     ● Arterial hypertension                            22.7      0.043       0.011-0.075         7.4          133
     ● Cardiac disease                                  0.6       0.009      \<0.001-0.020        1.6          133
     ● HIV                                              1.6       0.005      \<0.001-0.012        1.7          133
     ● Placenta previa                                  2.0       0.006      \<0.001-0.014        1.6          133
     ● Abruptio placentae                               4.8       0.005      \<0.001-0.013        1.9          133
     ● Uterine rupture                                  0.1       0.006      \<0.001-0.015        1.1          133
     ● Fetal malformation                               3.2       0.133       0.051-0.215         18.9         133
     ● Fetal macrosomia                                 1.7       0.002      \<0.001-0.008        1.4          133
     ● Maternal choice                                  1.0       0.037       0.008-0.065         7.2          133
     ● Other                                            17.1      0.082       0.027-0.137         14.9         133
  Type of incision (segmental transverse)               96.3      0.193       0.081-0.304         13.5         126

###### 

**Estimates of prevalence (P), intracluster correlation coefficients (ICC), their respective 95% CI, design effect (Deff), and mean cluster size (n**~**a**~**) for categorical newborn outcome variables**

  **Variable**                         **P(%)**   **ICC**   **95% CI for ICC**   **Deff**   **n**~**a**~
  ----------------------------------- ---------- --------- -------------------- ---------- --------------
  Diagnosis of gestational age (US)      45.4      0.264       0.128-0.399         84.8         265
  Stillborn                              3.1       0.026       0.006-0.046         7.5          265
  Intubation at delivery                 13.4      0.013       0.002-0.024         4.1          248
  Use of surfactant                      12.6      0.015       0.002-0.027         4.4          245
  Fetal malformation                     9.5       0.078       0.026-0.130         19.6         246
  Ventilatory support                    42.6      0.041       0.011-0.070         15.1         249
  Neonatal morbidity                     60.3      0.126       0.047-0.205         33.4         248
     ● Sepsis                            27.7      0.051       0.011-0.091         8.3          144
     ● Respiratory distress              73.4      0.061       0.014-0.107         9.9          148
     ● Pneumothorax                      3.6       0.041       0.007-0.075         8.2          141
     ● Cerebral hemorrhage (1--4)        8.7       0.052       0.007-0.097         5.8          114
     ● Lung hemorrhage                   3.7       0.028       0.004-0.053         5.7          143
     ● Hematologic dysfunction           51.0      0.267       0.116-0.417         71.7         146
     ● Endocrine dysfunction             22.0      0.119       0.036-0.201         30.3         145
     ● Renal dysfunction                 6.4       0.013      \<0.001-0.027        3.5          145
     ● Immune dysfunction                6.5       0.092       0.025-0.158         22.1         145
     ● Musculoskeletal morbidity         8.6       0.190       0.071-0.310         38.4         146
     ● Gastrointestinal dysfunction      43.2      0.340       0.168-0.512         70.6         146
     ● Hypovolemia                       10.4      0.026       0.003-0.049         6.0          146
     ● Necrotizing enterocolitis         2.4       0.020       0.001-0.038         3.2          145
     ● Convulsion/anticonvulsants        4.8       0.039       0.007-0.071         6.7          146
     ● Vasoactive amines                 12.2      0.019       0.001-0.037         3.5          146
     ● Pneumonia                         5.6       0.118       0.036-0.200         15.6         145
     ● Oxygen therapy with 28 days       8.0       0.021       0.002-0.041         3.8          145
     ● Oxygen therapy with 56 days       2.9       0.012      \<0.001-0.025        2.8          143
     ● Degree of retinopathy (1--3)      4.8       0.028      \<0.001-0.056        4.2           99
  Condition at discharge (live)          91.8      0.014       0.002-0.026         4.1          252

###### 

**Estimates of mean, intracluster correlation coefficients (ICC), their respective 95% CI, design effect (Deff), and mean cluster size (n**~**a**~**) for numeric newborn outcome variables**

  **Variable**                       **Mean**   **ICC**   **95% CI for ICC**   **Deff**   **n**~**a**~
  --------------------------------- ---------- --------- -------------------- ---------- --------------
  Gestational age (weeks)              34.5      0.031       0.008-0.055         10.4         265
  Birth weight (g)                    2321.1     0.033       0.009-0.058         11.6         264
  Birth weight 2° twin (g)            1905.2     0.007      \<0.001-0.043        1.4           21
  APGAR 1^st^ minute                   7.3       0.032       0.008-0.056         8.6          261
  APGAR 1^st^ minute 2° twin           6.7       0.042      \<0.001-0.098        2.2           21
  APGAR 5^th^ minute                   8.6       0.041       0.012-0.070         11.5         261
  APGAR 5^th^ minute 2° twin           8.3       0.002      \<0.001-0.034        1.1           21
  Head circumference (cm)              31.7      0.031       0.008-0.055         10.1         236
  Head circumference 2° twin (cm)      30.8      0.018      \<0.001-0.067        1.1           18
  Stature (cm)                         44.3      0.031       0.007-0.054         10.3         237
  Stature 2° twin (cm)                 42.3      0.025      \<0.001-0.077        1.4           18
  Length of ICU stay (days)            8.4       0.088       0.028-0.148         21.4         220
  Length of hospital stay (days)       13.3      0.037       0.009-0.065         8.5          235
  Age of newborn at sepsis (days)      4.6       0.173       0.054-0.292         7.2           39
  Age of newborn at death (days)       8.9       0.088      \<0.001-0.179        2.7           17

###### 

**Estimates of prevalence (P), intracluster correlation coefficients (ICC), their respective 95% CI, design effect (Deff), and mean cluster size (n**~**a**~**) for categorical management variables in spontaneous labor conditions or preterm due to pPROM**

  **Variable**                                   **P(%)**   **ICC**   **95% CI for ICC**   **Deff**   **n**~**a**~
  --------------------------------------------- ---------- --------- -------------------- ---------- --------------
  **Preterm birth due to spontaneous labor:**                                                               
  Use of corticosteroids                           28.5      0.032       0.002-0.062         5.2           73
  Corticosteroids (betamethasone)                  86.4      0.851       0.754-0.948         18.8          21
  Use of tocolytic agents                          23.6      0.068       0.015-0.121         8.7           72
  Association of tocolytic agents                  9.9       0.368       0.167-0.570         8.4           17
  Therapeutic failure of tocolysis                 11.4      0.165       0.029-0.301         4.3           17
  Use of magnesium sulphate (neuroprotection)      3.9       0.070       0.016-0.125         9.3           70
  Use of antibiotics                               42.8      0.262       0.117-0.407         28.8          72
  Intravenous antibiotic                           93.3      0.321       0.127-0.515         10.1          31
  Association of antibiotic                        15.3      0.144       0.025-0.263         12.9          30
  Group B streptococcus screening                  24.3      0.286       0.131-0.442         26.2          65
  **Preterm birth due to pPROM:**                                                                           
  Use of corticosteroids                           40.5      0.042       0.002-0.083         3.7           53
  Corticosteroids (betamethasone)                  85.0      0.965       0.941-0.990         23.5          21
  Use of tocolytic agents                          17.7      0.547       0.364-0.729         38.3          56
  Use of antibiotics                               78.2      0.233       0.095-0.371         18.3          54
  Intravenous antibiotic                           91.0      0.366       0.180-0.552         14.4          41
  Association of antibiotic                        20.9      0.245       0.093-0.397         20.1          41
  Group B streptococcus screening                  36.3      0.441       0.260-0.622         27.9          50
  Hydration solution (saline)                      11.0      0.419       0.235-0.602         20.1          52

###### 

**Estimates of prevalence (P), intracluster correlation coefficients (ICC), their respective 95% CI, design effect (Deff), and mean cluster size (n**~**a**~**) for diagnosis and management among categorical variables related to therapeutic preterm delivery**

  **Variable**                                                   **P(%)**   **ICC**   **95% CI for ICC**   **Deff**   **n**~**a**~
  ------------------------------------------------------------- ---------- --------- -------------------- ---------- --------------
  Therapeutic delivery for maternal disease                        74.6      0.102       0.032-0.172         9.6           73
  Therapeutic delivery for fetal disease                           54.1      0.065       0.016-0.115         7.0           73
  Maternal disease responsible for interruption of pregnancy:                                                        
     ● Diabetes                                                    7.3       0.063       0.011-0.115         5.5           54
     ● Gestational hypertension                                    12.9      0.144       0.048-0.240         9.4           54
     ● Chronic hypertension                                        15.3      0.009      \<0.001-0.027        1.8           54
     ● Preeclampsia                                                58.2      0.079       0.017-0.140         5.4           54
     ● Eclampsia                                                   3.2       0.017      \<0.001-0.041        1.8           54
     ● HELLP syndrome                                              9.4       0.012      \<0.001-0.031        1.2           54
     ● Abruptio placentae                                          7.7       0.009      \<0.001-0.026        1.6           54
     ● Previous placentae                                          3.3       0.001      \<0.001-0.013        0.8           54
  Fetal disease responsible for interruption of pregnancy:                                                           
     ● Fetal distress                                              32.6      0.052       0.010-0.095         6.1           71
     ● Fetal growth restriction                                    19.8      0.037       0.004-0.069         4.4           71
     ● Malformation                                                5.2       0.144       0.052-0.236         13.5          71
     ● Other fetal condition                                       15.1      0.161       0.061-0.262         15.8          71
  Exams to evaluate fetal condition:                                                                                        
     ● Cardiotocography                                            61.0      0.299       0.148-0.451         23.7          67
     ● Dopplerfluxometry                                           61.1      0.159       0.059-0.260         14.4          67
     ● Fetal biophysical profile                                   32.2      0.508       0.331-0.686         43.5          67
     ● Fetal movements control                                     4.3       0.101       0.030-0.172         12.3          67
     ● Other exam                                                  12.9      0.041       0.005-0.077         4.1           67
  Determinant exams for diagnosis:                                                                                          
     ● Cardiotocography                                            23.2      0.104       0.032-0.176         10.1          70
     ● Dopplerfluxometry                                           29.8      0.064       0.014-0.113         6.4           70
     ● Fetal biophysical profile                                   14.6      0.290       0.142-0.438         24.0          70
     ● Fetal echocardiography                                      1.2       0.030       0.001-0.058         4.6           70
     ● Maternal hepatic dysfunction                                15.9      0.194       0.079-0.308         19.9          70
     ● Maternal hematologic dysfunction                            21.0      0.278       0.134-0.423         29.9          70
     ● Other                                                       41.2      0.102       0.031-0.173         10.0          70
  Maternal or fetal attempted treatment                            57.9      0.056       0.012-0.101         5.7           71
  Use of corticosteroids                                           42.6      0.059       0.012-0.105         6.2           70
  Maternal condition at hospital discharge (cured)                 24.8      0.153       0.057-0.249         15.7          73

Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"} presents some variables related to maternal characteristics, including clinical and obstetrical history. ICCs ranged from \<0.001 to 0.145 (median 0.011). Table [3](#T3){ref-type="table"} shows the socio-demographic variables studied, and ICC ranged from 0.017 to 0.191 (median 0.041). Tables [4](#T4){ref-type="table"} and [5](#T5){ref-type="table"} presents variables related to pregnancy characteristics with ICC ranging from 0.001 to 0.386 (median 0.015). The variables related to labor conditions were presented in Table [6](#T6){ref-type="table"}. It can be observed that ICC ranged from 0.002 to 0.384, with a median of 0.022. Tables [7](#T7){ref-type="table"} and [8](#T8){ref-type="table"} shows variables related to perinatal outcomes and ICC were \< 0.1 in 81% of them. The most important outcome variable, newborn morbidities, is presented in Table [7](#T7){ref-type="table"}. Tables [9](#T9){ref-type="table"} and [10](#T10){ref-type="table"} present some variables analyzed specifically for preterm births and are related to management. Most variables in Table [9](#T9){ref-type="table"} showed ICC greater than 0.3 and the greatest ICC of this study (0.965) was relative to the variable "corticosteroids use", a management aspect well defined and well-established in all obstetric protocols, so there were high degree of homogeneity in clusters in these variables. The median of ICCs was 0.274. The median ICC in Table [10](#T10){ref-type="table"} was 0.079.

Estimated deffs
---------------

Estimated Deffs are presented in Tables [1](#T1){ref-type="table"}, [2](#T2){ref-type="table"}, [3](#T3){ref-type="table"}, [4](#T4){ref-type="table"}, [5](#T5){ref-type="table"}, [6](#T6){ref-type="table"}, [7](#T7){ref-type="table"}, [8](#T8){ref-type="table"}, [9](#T9){ref-type="table"} and [10](#T10){ref-type="table"} for each of 261 variables. Deff ranged from 0.6 to 148.0, with a median of 6.1.

Deff were under 5.0 in 74% of variables in Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}, ranging from 1.2 to 42.2 (median 3.65). Table [3](#T3){ref-type="table"} presents Deff values ranging from 2.8 to 60 (median 13.0). In variables related to gestational process (Tables [4](#T4){ref-type="table"} and [5](#T5){ref-type="table"}), Deff values ranged from 0.6 to 101.5 (median 4.9). The variables related to labor conditions (Table [6](#T6){ref-type="table"}) showed Deff ranging from 1.1 to 148 (median 6.6), with 60% of them under 8.0. In Tables [7](#T7){ref-type="table"} and [8](#T8){ref-type="table"}, related to perinatal outcomes, Deff values ranged from 1.1 to 84.8 (median 7.8). Tables [9](#T9){ref-type="table"} and [10](#T10){ref-type="table"} presented Deff median of 16.35 and 7.0, respectively.

We can observe that greater Deff median is present in process variables (Table [9](#T9){ref-type="table"}), and greater ICCs.

Discussion
==========

This study presents a large number of intracluster correlation coefficients whose values can be considered low (close to zero) in most variables, showing intracluster heterogeneity.

The greater ICC values were found in process variables, especially management in spontaneous preterm labor conditions, as corticosteroids use, Group B streptococcus screening, use of tocolytic agents and use of antibiotic. Indeed, the mean ICC value for these variables was 10 times higher than the mean ICC of the study. The variable with the highest ICC was "corticosteroids -- betamethasone", with a value of 0.965. The prevalence of this variable was 85%, showing a high degree of homogeneity in this management for preterm labor. These findings are in accordance with the literature that describes ICC values generally higher for variables related to process compared to those variables related to outcome \[[@B15],[@B16]\].

In the field of maternal and perinatal healthcare, Taljaard *et al.* calculated ICC values based on data obtained from secondary/tertiary services \[[@B16]\]. Comparing with our study, they found an overall median ICC of 0.067 versus 0.028. For maternal and newborn outcome variables, their median ICCs was 0.011 (versus 0.014), and 0.054 (versus 0.041), respectively. The findings of those investigators showed that, for variables associated to process, ICC values tend to be \> 0.07. The present findings are in agreement with this observation.

Pagel *et al.*\[[@B17]\] estimated ICC for a range of outcomes using data from five community-based clusters randomized controlled trials in three low-income countries. Estimated ICC values for mortality outcomes were lower than those for process outcomes, with narrower confidence intervals throughout for trials with larger number of clusters.

All comparisons show that the smaller the cluster size, the higher the ICC and the opposite occurs regarding the prevalence of the condition. Estimates of intracluster correlation are much less reliable for rare outcomes and the size of the cluster had a greater impact than the number of clusters on the reliability of estimates for rare outcomes \[[@B17]\].

Furthermore, higher healthcare levels tend to increase the degree of homogeneity \[[@B18],[@B19]\]. The size of ICC increases if the ICC represents data from secondary rather than primary care. This may be a reflection of the underlying heterogeneity of the datasets under consideration as the conditions represented across the different datasets were diverse. Although numerically small (average 0.01), such differences can have a substantial effect on sample size, even when the average of cluster is small \[[@B15]\]. The clusters in this study are secondary and tertiary hospitals, most of them are teaching hospitals, with the majority of procedures performed in conformity with evidence-based healthcare protocols.

Stratified randomization had the effect of reducing estimates of cluster correlation \[[@B15]\]. However, in the same way that in Brazilian Network for Surveillance of Severe Maternal Morbidity Study \[[@B20]\], which found ICC values close to zero, the selection of clusters did not performed stratification by region. The distribution of centers in this study, with almost half located in southeast region, is in accordance with the actual distribution of healthcare institutions and the proportionality of births per region in the country \[[@B21],[@B22]\].

The large number of intracluster correlation coefficients presented in this study, considered low (close to zero) in most of variables, can probably be seen as a good parameter of variance for calculating sample size in new studies in the field of perinatal and maternal health \[[@B15]\].

We can, however, to identify some possible limitations of the study, including the fact that we used a non-probabilistic sample from the centers (hospitals). Therefore, strictly speaking, the findings cannot be generalized to other populations. However, the majority of hospitals included in the study was third level referral hospitals taking care of high risk pregnancies and preterm babies. Probably the results would be applicable to other centers with such characteristics, irrespective of being private or public, especially in middle income countries like Brazil.

Conclusions
===========

The Brazilian Multicenter Study on Preterm Birth, developed as part of the Brazilian Network for Studies on Reproductive and Perinatal Health, to the best of our knowledge is the first cross sectional multicenter study on this topic in the country. It represents a planned comprehensive assessment of preterm birth in Brazil and ICC values calculation and analysis of more than 250 maternal and newborn variables, showed heterogeneity of data in selected clusters. These findings increase reliability of study estimates and allow the use of these results to calculate the required sample size for future research studies in maternal and perinatal health.
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